General MedicationsINJECTIONGeneric
DIHYDROERGOTAMINE MESYLATE
DIHYDROERGOTAMINE MESYLATE
Standard Dose
1MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Key Takeaways
- Primary indication: Review priority: STANDARD Marketing status: Discontinued
- Approval overview DIHYDROERGOTAMINE MESYLATE is listed in Drugs@FDA under application 216747 (ANDA).
- Review priority: STANDARD Marketing status: Discontinued Active ingredient DIHYDROERGOTAMINE MESYLATE Form and strength INJECTABLE;INJECTION - 1MG/ML Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-01-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview DIHYDROERGOTAMINE MESYLATE is listed in Drugs@FDA under application 216747 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DIHYDROERGOTAMINE MESYLATE Form and strength INJECTABLE;INJECTION - 1MG/ML Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-01-07 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.